Authors: AUZERIE J COLLE M GUINOT P LAVERGNE V

Citation: J. Auzerie et al., GROWTH-HORMONE RELEASING HORMONE-TREATMEN T IN GROWTH-HORMONE DEFICIENCY - ACTUAL DATA AND FUTURE-PROSPECTS, Archives de pediatrie, 2(4), 1995, pp. 365-372

Authors: BROCHET B GUINOT P ORGOGOZO JM CONFAVREUX C RUMBACH L LAVERGNE V BOULLIAT J CAUSSANEL JP CESARO P CHEDRU F COLLARD M DEGOS CF DESTEE A GOAS JY GONSETTE R FEVE JR ROULLET E SETIEY A VIALLET F WARTER JM

Citation: B. Brochet et al., DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY OF GINKGOLIDE-B IN TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 58(3), 1995, pp. 360-362

Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P

Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97

Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P

Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 196-196